Company Information
Overview
Founded in 1992, the establishment of Bioprojet Pharma marked a pivotal moment in gastroenterology with the discovery of a groundbreaking molecule. This innovation set the stage for significant advancements within the pharmaceutical sector. Research and development are central to its operations, with Bioprojet Biotech serving as a key hub located near Rennes. Approximately fifty specialists engage in creating new molecules and conducting preclinical evaluations across four dedicated units. Furthermore, this strategic focus on R&D underscores Bioprojet's commitment to enhancing therapeutic options while contributing to public health objectives. The company's longstanding dedication to scientific exploration solidifies its reputation as an authoritative figure within the industry, continuously striving for excellence in biopharmaceutical solutions.
Company size
2+ employees
Comprehensive Review
AI-Powered Reviews & RecommendationsThis AI-generated summary is based on available data and user feedback when available.
Write a review
All Reviews
0
total
No review for yet
Be the first to share your experience with this brand!
Reviews With Impact: Making a Difference
Trustima believe every experience deserves to be heard and every voice can make a difference. That's why we've launched our groundbreaking initiative - transforming your honest feedback into concrete environmental action. When you share your experience on our platform, you're not just helping others make informed decisions - you're directly contributing to reforestation efforts.
Start Now
Questions and Answers
Which areas does Bioprojet focus on within its operations?
Within its operations, Bioprojet focuses primarily on gastroenterology and biotechnology. The company's teams aim to discover and develop new therapeutic molecules while rigorously evaluating their efficacy in preclinical settings before progressing towards commercialization.
Why was Bioprojet Pharma established separately?
The establishment of Bioprojet Pharma as a separate entity allowed for a concentrated effort on marketing the newly discovered molecule in gastroenterology. This strategic decision facilitated better management of resources and expertise necessary for successful commercialization.
What is the origin of Bioprojet Pharma?
Bioprojet Pharma originated from the discovery of a new molecule in gastroenterology in 1992. This breakthrough led to the establishment of the company, which was created specifically to commercialize this innovative compound and marked the beginning of its significant success.
Where is Bioprojet's research center located?
The research center of Bioprojet, known as Bioprojet Biotech, is situated close to Rennes, France. This location serves as a hub for innovation within the company, fostering collaboration among researchers engaged in pharmaceutical development.
How does Bioprojet contribute to research and development?
Bioprojet contributes to research and development through its dedicated center, Bioprojet Biotech, located near Rennes. This facility houses around fifty collaborators who work across four units focused on creating new molecules and conducting preclinical evaluations for potential drug candidates.
